Phosphoinositide 3-kinase signalling--which way to target?
Wymann
Matthias P
MP
Department of Medicine, Division of Biochemistry, University of Fribourg, Rue du Musée 5, CH-1700 Fribourg, Switzerland. Matthias.Wymann@UniFR.ch
Zvelebil
Marketa
M
Laffargue
Muriel
M
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D008958:Models, Molecular; D015394:Molecular Structure; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism / Q000502:physiology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D021122:Protein Subunits; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
D004791:Enzyme Inhibitors; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D021122:Protein Subunits